A 66-Year-Old-Man with Metastatic Prostate Cancer - Episode 3

Factors for Consideration when Choosing an ADT Regimen for mCSPC

Jason Hafron, MD, revisits the patient profile and discusses factors that inform treatment decision-making in mCSPC.